Compare MOD & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOD | ARWR |
|---|---|---|
| Founded | 1916 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.1B |
| IPO Year | 1995 | 2009 |
| Metric | MOD | ARWR |
|---|---|---|
| Price | $200.27 | $60.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $212.67 | $81.50 |
| AVG Volume (30 Days) | 1.1M | ★ 2.1M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.87 | ★ 99.80 |
| EPS | ★ 0.90 | 0.22 |
| Revenue | ★ $1,352,500,000.00 | $16,142,321.00 |
| Revenue This Year | $22.59 | N/A |
| Revenue Next Year | $21.82 | N/A |
| P/E Ratio | ★ $206.12 | $270.84 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $64.79 | $10.66 |
| 52 Week High | $243.80 | $76.76 |
| Indicator | MOD | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 48.03 | 41.26 |
| Support Level | $125.19 | $60.60 |
| Resistance Level | $239.41 | $65.59 |
| Average True Range (ATR) | 13.40 | 2.94 |
| MACD | -6.46 | -0.24 |
| Stochastic Oscillator | 27.69 | 33.71 |
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.